Jing-hai Wan
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Role of Systemic Immunoinflammation Landscape in the Overall Survival of Patients with Leptomeningeal Metastases from Lung Cancer.
Journal: OncoTargets and therapy
Published: December 22, 2022
Identification of FKBP10 prognostic value in lung adenocarcinoma patients with surgical resection of brain metastases: A retrospective single-institution cohort study.
Journal: Clinics (Sao Paulo, Brazil)
Published: November 14, 2022
Multidimensional modulation of systemic immune by neurosurgical tumor resection in patients with brain tumors.
Journal: Immunity, inflammation and disease
Published: July 21, 2022
L1CAM expression in either metastatic brain lesion or peripheral blood is correlated with peripheral platelet count in patients with brain metastases from lung cancer.
Journal: Frontiers in oncology
Published: July 10, 2022
Systemic immune-inflammation landscape in brain metastasis needing neurosurgical resection: Analysis of 230 consecutive cases in a single center.
Journal: Immunity, inflammation and disease
Published: April 09, 2022
Preoperative blood testing for glioblastoma, brain metastases, and primary central nervous system lymphoma differentiation.
Journal: Translational cancer research
Published: September 15, 2021
Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma.
Journal: Immunity, inflammation and disease
Published: June 10, 2021
Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas.
Journal: Frontiers in oncology
Published: October 11, 2019
High S phase kinase-associated protein 2 expression is a potential prognostic biomarker for glioma.
Journal: Oncology letters
Published: July 28, 2019
Sanbo Scoring System, Based on Age and Pre-treatment Hematological Markers, is a Non-invasive and Independent Prognostic Predictor for Patients with Primary Glioblastomas: A Retrospective Multicenter Study.
Journal: Journal of Cancer
Published: January 11, 2019
Last Updated: 09/26/2026